About AB Science

AB Science: Innovation at the heart of our scientific approach ? 

AB Science is a pharmaceutical company specializing in the research, development, and commercialization of tyrosine kinase inhibitors, a new class of targeted therapeutic molecules which act by modifying signalling pathways within cells. The company focuses its research on pathologies with high unmet medical need (cancers, inflammatory diseases and central nervous system diseases) in human and veterinary medicine.  

Focused on benefiting the patient, AB Science pursues a clear objective: transform fundamental science into medicine.   


AB Science: become an integrated "pharma" laboratory  

AB Science made the decision to become an integrated pharmaceutical company, which develops its molecules up through the authorization for market launch and commercializes them directly. This strategy offers the best potential for value creation, allowing the company to retain all operating income. .